Growth hormone-releasing hormone receptor antagonists modify molecular machinery in the progression of prostate cancer

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Tumor-Induced Pressure in the Bone Microenvironment Causes Osteocytes to Promote the Growth of Prostate Cancer Bone Metastases

(2015) Joseph L. Sottnik et al.   CANCER RESEARCH

The epithelial to mesenchymal transition in pancreatic cancer: A systematic review

(2015) Mircea Beuran et al.   PANCREATOLOGY

Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models

(2014) Laura Muñoz-Moreno et al.   INVESTIGATIONAL NEW DRUGS

Activation of c-Myc and Cyclin D1 by JCV T-Antigen and β-Catenin in Colon Cancer

(2014) Michael J. Ripple et al.   PLoS One

Interplay of VEGFa and MMP2 regulates invasion of glioblastoma

(2014) Jie Gong et al.   TUMOR BIOLOGY

CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells

(2013) Guoqiang Chang et al.   Cancer Cell International

Pharmacological modulation of beta-catenin and its applications in cancer therapy

(2013) Ravi Thakur et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

The role of p21Waf1/CIP1 as a Cip/Kip type cell-cycle regulator in oral squamous cell carcinoma (Review).

(2013) M. Perez-Sayans et al.   Medicina Oral Patologia Oral y Cirugia Bucal

Inhibitory effects of antagonists of growth hormone-releasing hormone on growth and invasiveness of PC3 human prostate cancer

(2012) Laura Muñoz-Moreno et al.   INTERNATIONAL JOURNAL OF CANCER

New Insights into p53 Signaling and Cancer Cell Response to DNA Damage: Implications for Cancer Therapy

(2012) Razmik Mirzayans et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases

(2012) F. G. Rick et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression

(2012) Grégoire F. Le Bras et al.   Cell Adhesion & Migration

Role of E-cadherin in Antimigratory and Antiinvasive Efficacy of Silibinin in Prostate Cancer Cells

(2011) G. Deep et al.   Cancer Prevention Research

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells

(2011) Florian Hohla et al.   CELL CYCLE

The role of the cell adhesion molecules (integrins / cadherins) in prostate cancer

(2011) Alexandros Drivalos et al.   International Braz J Urol

Control of Advanced Cancer: The Road to Chronicity

(2011) Agustin Lage et al.   International Journal of Environmental Research and Public Health

GHRH antagonists reduce the invasive and metastatic potential of human cancer cell lines in vitro

(2010) Szabolcs Bellyei et al.   CANCER LETTERS

Antagonists of growth hormone-releasing hormone inhibit the proliferation of human benign prostatic hyperplasia cells

(2010) Agnieszka Siejka et al.   PROSTATE

Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells

(2009) Ana B. Fernández-Martínez et al.   PROSTATE

Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways

(2008) T. T. Onder et al.   CANCER RESEARCH

New Treatment Approaches for Prostate Cancer Based on Peptide Analogues

(2008) Anton Stangelberger et al.   EUROPEAN UROLOGY

Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer

(2007) Andrew V Schally et al.   Nature clinical practice. Endocrinology & metabolism